Venous thromboprophylaxis in UK medical inpatients

Journal of the Royal Society of Medicine

Volumn 98, Issue 11, 2005, Pages 507-512

  Rashid, S T ^a,e   Thursz, M R ^b   Razvi, N A ^c   Voller, R ^d   Orchard, T ^b   Shlebak, Abdul A ^b  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^b IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

^c UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

^d UNIVERSITY OF LEEDS   (United Kingdom)

^e Yorkshire Deanery   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ENOXAPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ARTICLE; AWARENESS; CLINICAL PRACTICE; COMPARATIVE STUDY; CONSENSUS; CONTROLLED STUDY; HEALTH CARE UTILIZATION; HOSPITAL PATIENT; HUMAN; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MEDICAL SOCIETY; PATIENT SATISFACTION; PRACTICE GUIDELINE; PRESCRIPTION; PROPHYLAXIS; RISK ASSESSMENT; RISK FACTOR; STATISTICAL SIGNIFICANCE; TEACHING HOSPITAL; UNITED KINGDOM; VENOUS THROMBOEMBOLISM;

EID: 27744549414     PISSN: 01410768     EISSN: None     Source Type: Journal    
DOI: 10.1258/jrsm.98.11.507     Document Type: Article

References (28)

1. Nordstrom M, Lindblad B, Bergqvist D, Kjellstrom T. A prospective study of the incidence of deep-vein thrombosis within a defined urban population. J Intern Med 1992;232:155-60
2. Anderson FA Jr, Wheeler HB, Goldberg RJ, et al. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study. Arch Intern Med 1991;151:933-8
3. Carter CJ. The natural history and epidemiology of venous thrombosis. Prog Cardiovasc Dis 1994;36:423-38
4. Fowkes FJ, Price JF, Fowkes FG. Incidence of diagnosed deep vein thrombosis in the general population: systematic review. Eur J Vasc Endovasc Surg 2003;25:1-5
5. White RH. The epidemiology of venous thromboembolism. Circulation 2003;107:14-18
6. Virchow RR. Cellular Pathology. London: Churchill, 1860
7. Cohen AT, Alikhan R. Prophylaxis of venous thromboembolism in medical patients. Curr Opin Pulm Med 2001;7:332-7
8. Heit JA, Silverstein MD, Mohr DN, Petterson TM, O'Fallon WM, Melton LJ III. Predictors of survival after deep vein thrombosis and pulmonary embolism: a population-based, cohort study. Arch Intern Med 1999;159:445-53
9. Simonneau G, Sors H, Charbonnier B, et al. A comparison of low-molecular-weight heparin with unfractionated heparin for acute pulmonary embolism. The THESEE Study Group. Tinzaparine ou Heparine Standard: Evaluations dans l'Embolie Pulmonaire. N Engl J Med 1997;337:663-9
10. Carson JL, Kelley MA, Duff A, et al. The clinical course of pulmonary embolism. N Engl J Med 1992;326:1240-5
11. Low-molecular-weight heparin in the treatment of patients with venous thromboembolism. The Columbus Investigators. N Engl J Med 1997;337:657-62
12. Brandjes DP, Buller HR, Heijboer H, et al. Randomised trial of effect of compression stockings in patients with symptomatic proximal-vein thrombosis. Lancet 1997;349:759-62
13. Goldhaber SZ, Dunn K, MacDougall RC. New onset of venous thromboembolism among hospitalized patients at Brigham and Women's Hospital is caused more often by prophylaxis failure than by withholding treatment. Chest 2000;118:1680-4
14. Mismetti P, Laporte-Simitsidis S, Tardy B, et al. Prevention of venous thromboembolism in internal medicine with unfractionated or low-molecular-weight heparins: a meta-analysis of randomised clinical trials. Thromb Haemost 2000;83:14-19
15. Samama MM, Cohen AT, Darmon JY, et al. A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group. N Engl J Med 1999; 341:793-800
16. Turpie AG. Thrombosis prophylaxis in the acutely ill medical patient: insights from the prophylaxis in MEDical patients with ENOXaparin (MEDENOX) trial. Am J Cardiol 2000;86:48-52M
17. Geerts WH, Pineo GF, Heit JA, et al. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004;126:338-400S
18. Geerts WH, Heit JA, Clagett GP, et al. Prevention of venous thromboembolism. Chest 2001;119:132-75S
19. Campbell SE, Walke AE, Grimshaw JM, et al. The prevalence of prophylaxis for deep vein thrombosis in acute hospital trusts. Int J Qual Health Care 2001;13:309-16
20. Stark JE, Kilzer WJ. Venous thromboembolic prophylaxis in hospitalized medical patients. Ann Pharmacother 2004;38:36-40
21. Rahim SA, Panju A, Pai M, Ginsberg J. Venous thromboembolism prophylaxis in medical inpatients: a retrospective chart review. Thromb Res 2003;111:215-19
22. Ageno W, Squizzato A, Ambrosini F, et al. Thrombosis prophylaxis in medical patients: a retrospective review of clinical practice patterns. Haematologica 2002;87:746-50
23. Abba AA, Al Ghonaim MA, Rufai AM. Physicians' practice for prevention of venous thromboembolism in medical patients. J Coll Physicians Surg Pak 2004;14:211-14
24. Harinath G, St John PH. Use of a thromboembolic risk score to improve thromboprophylaxis in surgical patients. Ann R Coll Surg Engl 1998;80:347-9
25. Huang A, Barber N, Northeast A. Deep vein thrombosis prophylaxis protocol-needs active enforcement. Ann R Coll Surg Engl 2000;82: 69-70
26. Agu O, Handa A, Hamilton G, Baker DM. Deep vein thrombosis prophylaxis: audit of practice in general surgical patients in a teaching hospital. Phlebology 2000;15:71-4.
27. Risk of and prophylaxis for venous thromboembolism in hospital patients. Thromboembolic Risk Factors (THRIFT) Consensus Group. BMJ 1992;305:567-74
28. Risk of and prophylaxis for venous thromboembolism in hospital patients. Phlebology 1998;13:87-97